Correlation Between SCOTT TECHNOLOGY and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SCOTT TECHNOLOGY and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCOTT TECHNOLOGY and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SCOTT TECHNOLOGY and Novo Nordisk AS, you can compare the effects of market volatilities on SCOTT TECHNOLOGY and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCOTT TECHNOLOGY with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCOTT TECHNOLOGY and Novo Nordisk.

Diversification Opportunities for SCOTT TECHNOLOGY and Novo Nordisk

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between SCOTT and Novo is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding SCOTT TECHNOLOGY and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and SCOTT TECHNOLOGY is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCOTT TECHNOLOGY are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of SCOTT TECHNOLOGY i.e., SCOTT TECHNOLOGY and Novo Nordisk go up and down completely randomly.

Pair Corralation between SCOTT TECHNOLOGY and Novo Nordisk

Assuming the 90 days trading horizon SCOTT TECHNOLOGY is expected to generate 0.9 times more return on investment than Novo Nordisk. However, SCOTT TECHNOLOGY is 1.11 times less risky than Novo Nordisk. It trades about 0.14 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.13 per unit of risk. If you would invest  99.00  in SCOTT TECHNOLOGY on October 26, 2024 and sell it today you would earn a total of  26.00  from holding SCOTT TECHNOLOGY or generate 26.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SCOTT TECHNOLOGY  vs.  Novo Nordisk AS

 Performance 
       Timeline  
SCOTT TECHNOLOGY 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SCOTT TECHNOLOGY are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical indicators, SCOTT TECHNOLOGY exhibited solid returns over the last few months and may actually be approaching a breakup point.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

SCOTT TECHNOLOGY and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SCOTT TECHNOLOGY and Novo Nordisk

The main advantage of trading using opposite SCOTT TECHNOLOGY and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCOTT TECHNOLOGY position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind SCOTT TECHNOLOGY and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets